Literature DB >> 29986991

Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.

Caitlin K Moynihan1, Panne A Burke1, Sarah A Evans1, Amie C O'Donoghue1, Helen W Sullivan2.   

Abstract

BACKGROUND: Prescription drug marketing to physicians often includes clinical trial data. Prior research has shown that physicians may not have the necessary knowledge to understand all clinical trial results and they can be influenced by how these results are reported. This study focused on physicians' reactions to and evaluations of clinical trial data presented in professional prescription drug promotion.
METHODS: We conducted 60-minute interviews with practicing physicians across the United States (50 primary care physicians and 22 endocrinologists). Physicians viewed prescription drug promotional materials that contained clinical trial data and answered follow-up questions.
RESULTS: Physicians demonstrated low to moderate knowledge about clinical trial-related terms found in promotional prescription drug materials. DISCUSSION: Results from this qualitative analysis underscore a need to determine how clinical trial data in prescription drug promotional materials affect physicians' attitudes and decision making. © Copyright 2018 by the American Board of Family Medicine.

Entities:  

Keywords:  Endocrinologists; Marketing; Prescriptions; Primary Care Physicians

Mesh:

Substances:

Year:  2018        PMID: 29986991      PMCID: PMC6112155          DOI: 10.3122/jabfm.2018.04.170242

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  8 in total

1.  Clinician attitudes toward biostatistics.

Authors:  Colin P West; Robert D Ficalora
Journal:  Mayo Clin Proc       Date:  2007-08       Impact factor: 7.616

2.  Medicine residents' understanding of the biostatistics and results in the medical literature.

Authors:  Donna M Windish; Stephen J Huot; Michael L Green
Journal:  JAMA       Date:  2007-09-05       Impact factor: 56.272

3.  The use of saturation in qualitative research.

Authors:  Janiece L Walker
Journal:  Can J Cardiovasc Nurs       Date:  2012

4.  Completeness of reporting trial results: effect on physicians' willingness to prescribe.

Authors:  M Bobbio; B Demichelis; G Giustetto
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

Review 5.  Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review.

Authors:  Leila Kahwati; Dennis Carmody; Nancy Berkman; Helen W Sullivan; Kathryn J Aikin; Jessica DeFrank
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

Review 6.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069

7.  Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration.

Authors:  H C Bucher; M Weinbacher; K Gyr
Journal:  BMJ       Date:  1994-09-24

8.  Promotion of prescription drugs to consumers and providers, 2001-2010.

Authors:  Rachel Kornfield; Julie Donohue; Ernst R Berndt; G Caleb Alexander
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  8 in total
  3 in total

1.  Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion.

Authors:  Vanessa Boudewyns; Amie C O'Donoghue; Ryan S Paquin; Kathryn J Aikin; Kate Ferriola-Bruckenstein; Victoria M Scott
Journal:  Oncologist       Date:  2021-09-28

2.  Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study.

Authors:  Melanie C Chansky; Simani M Price; Kathryn J Aikin; Amie C O'Donoghue
Journal:  BMC Prim Care       Date:  2022-04-19

3.  A follow-up study on the effects of an educational intervention against pharmaceutical promotion.

Authors:  M Murat Civaner
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.